Key Record Dates
ClinicalTrials.gov Identifier: | NCT03425279 |
---|---|
Brief Title: | Phase 2 CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma |
First Submitted : | January 22, 2018 |
First Submitted that Met QC Criteria : | February 6, 2018 |
First Posted : | February 7, 2018 |
Last Update Submitted that Met QC Criteria : | September 7, 2021 |
Last Update Posted : | September 13, 2021 |